Whalerock Point Partners, LLC Gilead Sciences, Inc. Transaction History

Whalerock Point Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $240,637 - $302,560	-3,875 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $94,042 - $109,200	-1,300 Reduced 25.12%	3,875 $298,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $41,273 - $52,864	-659 Reduced 11.3%	5,175 $387,000
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $83,864 - $92,248	-1,361 Reduced 18.92%	5,834 $379,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $2,750 - $3,036	-44 Reduced 0.61%	7,195 $456,000
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $35,642 - $39,928	570 Added 8.55%	7,239 $471,000
Q4 2018 Mar 04, 2019	SELL	$60.54 - $79.0 $45,405 - $59,250	-750 Reduced 10.11%	6,669 $417,000
Q3 2018 Mar 04, 2019	SELL	$71.28 - $78.92 $69,498 - $76,947	-975 Reduced 11.62%	7,419 $573,000
Q2 2018 Mar 04, 2019	SELL	$64.88 - $75.68 $593,652 - $692,472	-9,150 Reduced 52.15%	8,394 $595,000
Q1 2018 Apr 05, 2018	SELL	$72.84 - $88.8 $480,015 - $585,192	-6,590 Reduced 27.31%	17,544 $1.32 Million
Q4 2017 Jan 16, 2018	SELL	$71.15 - $83.52 $471,368 - $553,320	-6,625 Reduced 21.54%	24,134 $1.73 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $2.22 Million - $2.63 Million	30,759	30,759 $2.49 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Whalerock Point Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Whalerock Point Partners, LLC with notifications on news.